Advanced search
Publication Cover
Postgraduate Medicine Volume 130, 2018 - Issue 1
Submit an article Journal homepage
2,887
Views
14
CrossRef citations to date
0
Altmetric
Clinical Features - Original Research

Effects of SHP465 mixed amphetamine salts in adults with ADHD in a simulated adult workplace environment

Timothy WigalAVIDA Inc., Newport Beach, CA, USACorrespondence[email protected]
View further author information
,
Ann ChildressCenter for Psychiatry and Behavioral Medicine, Las Vegas, NV, USAView further author information
,
Glen FrickFormerly of Global Clinical Development, Shire, Lexington, MA, USAView further author information
,
Brian YanBiostatistics, Shire, Lexington, MA, USAView further author information
,
Sharon WigalAVIDA Inc., Newport Beach, CA, USAView further author information
&
Manisha MadhooGlobal Medical Affairs, Shire, Lexington, MA, USAView further author information
Pages 111-121 | Received 14 Jul 2017, Accepted 04 Oct 2017, Published online: 31 Oct 2017

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Kendall Abbas, Elizabeth W. Barnhardt, Patricia L. Nash, Maria Streng & Daniel L. Coury. (2024) A review of amphetamine extended release once-daily options for the management of attention-deficit hyperactivity disorder. Expert Review of Neurotherapeutics 24:4, pages 421-432.
Read now
Ann Childress & Shelby Burton. (2022) Evaluating the pharmacokinetics of extended release viloxazine in the treatment of children with attention-deficit/hyperactivity disorder. Expert Opinion on Drug Metabolism & Toxicology 18:6, pages 357-366.
Read now
Sharon Wigal, Frank Lopez, Glen Frick, Brian Yan, Brigitte Robertson & Manisha Madhoo. (2019) A randomized, double-blind, 3-way crossover, analog classroom study of SHP465 mixed amphetamine salts extended-release in adolescents with ADHD. Postgraduate Medicine 131:3, pages 212-224.
Read now
Timothy Wigal, Matthew Brams, Glen Frick, Brian Yan & Manisha Madhoo. (2018) A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design. Postgraduate Medicine 130:5, pages 481-493.
Read now

Articles from other publishers (10)

Craig B. H. Surman, Daniel M. Walsh & Joseph B. Bond. (2024) Comparing Pharmacotherapies for ADHD in Adults: Evidence From Outcome-Focused Analysis of Food and Drug Administration Drug Label Registration Trials. Journal of Attention Disorders 28:5, pages 800-809.
Crossref
Ann Childress, Maggie Sibley, Mary V. Solanto, Max Wiznitzer & Jeffrey H. Newcorn. (2023) Guidelines in the United States for the Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Why They Are Needed. Psychiatric Annals 53:10, pages 461-469.
Crossref
Scout McWilliams, Ted Zhou, Sylvia Stockler, Dean Elbe & Osman S. Ipsiroglu. (2022) Sleep as an outcome measure in ADHD randomized controlled trials: A scoping review. Sleep Medicine Reviews 63, pages 101613.
Crossref
Ann Childress, Andrew J. Cutler, Andrea H. Marraffino, Sailaja Bhaskar & Graeme Donnelly. (2021) Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Treatment of ADHD. Journal of Attention Disorders 26:6, pages 857-869.
Crossref
Margaret D. Weiss, Ann C. Childress & Graeme A.E. Donnelly. (2020) Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension. Journal of Attention Disorders 25:10, pages 1417-1428.
Crossref
Ann C. Childress. (2021) Novel Formulations of ADHD Medications: Stimulant Selection and Management. FOCUS 19:1, pages 31-38.
Crossref
Martin A. Katzman, Greg Mattingly, Larry J. Klassen, Marc J. Cataldo & Graeme A. E. Donnelly. (2020) Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults. Journal of Clinical Psychopharmacology 40:6, pages 579-587.
Crossref
Greg MattinglyValerie ArnoldBrian YanMing YuBrigitte Robertson. (2020) A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 30:9, pages 549-557.
Crossref
Jesse Elliott, Amy Johnston, Don Husereau, Shannon E. Kelly, Caroline Eagles, Alice Charach, Shu-Ching Hsieh, Zemin Bai, Alomgir Hossain, Becky Skidmore, Eva Tsakonas, Dagmara Chojecki, Muhammad Mamdani & George A. Wells. (2020) Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis. PLOS ONE 15:10, pages e0240584.
Crossref
Sharon B. Wigal. (2019) Laboratory School Protocol Mini-Review: Use of Direct Observational and Objective Measures to Assess ADHD Treatment Response Across the Lifespan. Frontiers in Psychology 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.